This study suggested that elevated levels of CLU in several human cancers might promote tumour progression by interfering with pro-apoptotic pathways by interaction with activated Bax, thereby inhibiting cytochrome C release and apoptosis [8]. This evidence concerns the gene CLU and cancer.